Go Pro
NASDAQ:CMRA

Comera Life Sciences (CMRA) Stock Price, News & Analysis

Comera Life Sciences logo
$0.0001 +0.00 (+∞)
As of 12:13 PM Eastern

About Comera Life Sciences Stock (NASDAQ:CMRA)

Advanced

Key Stats

Today's Range
$0.0001
▼
$0.0001
50-Day Range
N/A
52-Week Range
$0.0001
▼
$0.0002
Volume
31,500 shs
Average Volume
8,113 shs
Market Capitalization
$3.07 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Comera Life Sciences Holdings, Inc. is a biotechnology company focused on improving the development, formulation and delivery of protein-based therapeutics, including biologic drugs and vaccines. The company’s work is intended to help enhance the stability, shelf life and administration of complex biological medicines.

Comera’s technology platform, known as SQore, is designed to use proprietary excipients and formulation approaches to stabilize proteins and other biologic molecules. The platform may support the development of injectable and potentially alternative delivery formats, with applications across a range of therapeutic products.

The company has also provided formulation-development and related scientific services to biopharmaceutical companies. Comera Life Sciences is based in the United States and serves the broader biopharmaceutical industry. Publicly available information about its current commercial operations and leadership is limited.

AI Generated. May Contain Errors.

Receive CMRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Comera Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CMRA Stock News Headlines

MILLIONAIRE MASTERCLASS INVITE: Altucher
James Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation.tc pixel
See More Headlines

CMRA Stock Analysis - Frequently Asked Questions

Comera Life Sciences' stock was trading at $0.0001 at the start of the year. Since then, CMRA stock has increased by 0.0% and is now trading at $0.0001.

Shares of CMRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Comera Life Sciences investors own include Sangamo Therapeutics (SGMO), NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Jabil (JBL) and Adobe (ADBE).

Company Calendar

Today
9/24/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:CMRA
CIK
1907685
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$1.00 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
30,740,000
Free Float
28,002,000
Market Cap
$3.07 thousand
Optionable
Not Optionable
Beta
1.05
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:CMRA) was last updated on 9/24/2026 by MarketBeat.com Staff.
From Our Partners